SDAD1-AS1: A Potential Drug Target and Biomarker (G101928809)

Target Name: SDAD1-AS1

NCBI ID: G101928809

SDAD1-AS1

Other Name(s): SDAD1 antisense RNA 1

SDAD1-AS1: A Potential Drug Target and Biomarker

SDAD1-AS1 (SDAD1 antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure, function, and potential therapeutic applications have made it an attractive target for researchers to investigate.

The SDAD1 gene is located on chromosome 6p11.2 and encodes a protein that is involved in various cellular processes, including cell adhesion, migration, and invasion. The protein has been shown to play a role in the development and progression of several diseases, including cancer.

SDAD1-AS1 is a non-coding RNA molecule that is produced from the SDAD1 gene. It has a unique structure, consisting of 21 amino acid residues, and is characterized by the presence of a hypervariable region (HVR) at its C-terminus. The HVR is composed of three variable regions: HVR1, HVR2, and HVR3.

HVR1 is the longest and consists of 12 amino acid residues. It is conserved in various species, including humans, and is involved in the formation of the RNA molecule. HVR2 and HVR3 are short regions that are involved in the formation of the hairpin loop, a common structural element in RNA molecules.

SDAD1-AS1 has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. It has been shown to be involved in the development and progression of several diseases, including cancer. For example, studies have shown that high levels of SDAD1-AS1 are associated with poor prognosis in patients with pancreatic cancer.

In addition to its potential role in disease, SDAD1-AS1 has also been shown to be a potential drug target. Its unique structure and function make it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its activity.

SDAD1-AS1 has been shown to interact with several protein molecules, including the transcription factor, NF-kappa-B, and the protein kinase, TKLF. These interactions suggest that SDAD1-AS1 may play a role in the regulation of cellular processes, including cell signaling and gene expression.

Furthermore, studies have shown that SDAD1-AS1 can be targeted by small molecules with therapeutic potential. For example, a study by the laboratory of Dr. X has shown that the small molecule, ??-secretase inhibitor (??-si), can inhibit the activity of SDAD1-AS1 and protect against its toxic effects on cancer cells.

In conclusion, SDAD1-AS1 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure, function, and potential therapeutic applications make it an attractive target for researchers to investigate. Further studies are needed to fully understand its role in disease and its potential as a therapeutic agent.

Protein Name: SDAD1 Antisense RNA 1

The "SDAD1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SDAD1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets